General Information of Drug (ID: DMGWC86)

Drug Name
OMP-52M51 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMGWC86

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Notch-1 receptor (NOTCH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
LY3039478 DMC5SAW Solid tumour/cancer 2A00-2F9Z Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Notch-1 receptor (NOTCH1) TTB1STW NOTC1_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT01703572) A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 741867).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)